{"id":59771,"date":"2024-02-28T06:15:46","date_gmt":"2024-02-28T06:15:46","guid":{"rendered":"https:\/\/medsname.com\/waf-5\/"},"modified":"2026-05-01T10:49:15","modified_gmt":"2026-05-01T10:49:15","slug":"waf-5","status":"publish","type":"product","link":"https:\/\/medsbase.com\/sv\/product\/waf-5\/","title":{"rendered":"Waf-5"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Waf-5?<\/h3>\n<p style=\"margin:0;\"><strong>Waf-5<\/strong> is 5 mg warfarin tablets from a WHO-GMP certified manufacturer &mdash; vitamin K antagonist (VKA) &mdash; oral anticoagulant. Warfarin was introduced in 1954 after synthesis from dicoumarol (the rat poison compound that caused cattle haemorrhage after spoiled sweet clover consumption in 1920s Wisconsin). Named after the Wisconsin Alumni Research Foundation (WARF) that funded its development. Remains essential for mechanical heart valves, moderate-severe mitral stenosis, and patients where DOACs are contraindicated. blocks vitamin K epoxide reductase (VKORC1), preventing regeneration of reduced vitamin K required for carboxylation of clotting factors II, VII, IX, X and proteins C and S. Takes 3-5 days to reach full effect (factor II half-life ~60 hours). Dosing: <strong>Individualised to INR target<\/strong> (2.0-3.0 for most indications; 2.5-3.5 for mechanical valves). Starting dose 5 mg daily for 2-3 days then adjusted by INR; 2-4 mg daily typical maintenance; wide inter-individual variation driven by CYP2C9 and VKORC1 genotype plus diet. <strong>Bl\u00f6dningsrisk:<\/strong> major bleeding ~3-5%\/year at therapeutic INR; rises sharply with supratherapeutic INR, acute illness, and interacting drugs. Reversal with vitamin K (slow, hours), 4-factor PCC, or fresh frozen plasma (emergencies). Anticoagulant and antiplatelet selection is individualised to diagnosis, bleeding risk, renal function, and drug interactions. Specialist or family-physician supervision is standard.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Vad du f\u00e5r med MedsBase:<\/strong> WHO-GMP-certifierad tillverkare \u00b7 Diskret f\u00f6rpackning \u00b7 V\u00e4rldsvid leverans \u00b7 1 400+ verifierade <a href=\"https:\/\/medsbase.com\/sv\/reviews\/\">kundrecensioner<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Varje best\u00e4llning omfattas av v\u00e5r <a href=\"https:\/\/medsbase.com\/sv\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 om din f\u00f6rs\u00e4ndelse inte anl\u00e4nder inom 20 arbetsdagar, skickar vi om den.<\/p>\n<h3>Varf\u00f6r best\u00e4lla fr\u00e5n MedsBase<\/h3>\n<p>V\u00e5ra generiska l\u00e4kemedel kommer fr\u00e5n WHO-GMP-certifierade tillverkare och skickas v\u00e4rldsvidt i diskreta, enkla f\u00f6rpackningar \u2014 inget l\u00e4kemedelsnamn p\u00e5 f\u00f6rs\u00e4ndelsens utsida. Kortbetalningar hanteras via en reglerad betalningsprocessor (kontoutdrag visar en reglerad kortbetalningsprocessor \u2014 aldrig \u201cMedsBase\u201d eller n\u00e5got l\u00e4kemedelsnamn). Krypto och SEPA-bank\u00f6verf\u00f6ring accepteras ocks\u00e5. Varje best\u00e4llning backas upp av v\u00e5r Reshipment Assurance Policy.<\/p>\n<h2 class=\"wp-block-heading\">What Is Waf-5?<\/h2>\n<p>Waf-5 is 5 mg warfarin tablets from a WHO-GMP certified manufacturer, supplied in 30-180 tablets. Warfarin was introduced in 1954 after synthesis from dicoumarol (the rat poison compound that caused cattle haemorrhage after spoiled sweet clover consumption in 1920s Wisconsin). Named after the Wisconsin Alumni Research Foundation (WARF) that funded its development. Remains essential for mechanical heart valves, moderate-severe mitral stenosis, and patients where DOACs are contraindicated.<\/p>\n<h2 class=\"wp-block-heading\">Hur Warfarin fungerar<\/h2>\n<p>Warfarin blocks vitamin K epoxide reductase (VKORC1), preventing regeneration of reduced vitamin K required for carboxylation of clotting factors II, VII, IX, X and proteins C and S. Takes 3-5 days to reach full effect (factor II half-life ~60 hours).<\/p>\n<h2 class=\"wp-block-heading\">Godk\u00e4nda Anv\u00e4ndningsomr\u00e5den<\/h2>\n<ul>\n<li><strong>Mekaniska hj\u00e4rtklaffar<\/strong> &mdash; only warfarin is approved (DOACs are contraindicated)<\/li>\n<li><strong>Moderate-severe mitral stenosis with AF<\/strong> &mdash; warfarin preferred<\/li>\n<li><strong>F\u00f6rmaksflimmer<\/strong> &mdash; DOACs are now first-line in most markets; warfarin remains where DOACs are contraindicated (severe CKD, concurrent strong inhibitors)<\/li>\n<li><strong>VTE treatment and secondary prevention<\/strong> &mdash; largely displaced by DOACs<\/li>\n<li><strong>Antiphospholipid syndrome<\/strong> &mdash; warfarin still preferred (RCTs suggested DOAC inferiority)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Dosering<\/h2>\n<p><strong>Individualised to INR target<\/strong> (2.0-3.0 for most indications; 2.5-3.5 for mechanical valves). Starting dose 5 mg daily for 2-3 days then adjusted by INR; 2-4 mg daily typical maintenance; wide inter-individual variation driven by CYP2C9 and VKORC1 genotype plus diet.<\/p>\n<h2 class=\"wp-block-heading\">Bl\u00f6dningsrisk och \u00f6vervakning<\/h2>\n<p><strong>Bl\u00f6dningsrisk:<\/strong> major bleeding ~3-5%\/year at therapeutic INR; rises sharply with supratherapeutic INR, acute illness, and interacting drugs. Reversal with vitamin K (slow, hours), 4-factor PCC, or fresh frozen plasma (emergencies).<\/p>\n<p><strong>INR monitoring is essential.<\/strong> Check every 3-4 days on initiation until stable; then weekly-fortnightly for a month; then monthly once stable (or longer in experienced patients). Acute illness, antibiotic courses, diet changes, and new medications all warrant earlier checks.<\/p>\n<h2 class=\"wp-block-heading\">Biverkningar<\/h2>\n<ul>\n<li>Bleeding &mdash; major 3-5%\/year at therapeutic INR<\/li>\n<li>Warfarin skin necrosis (rare; 3-10 days after initiation, especially in protein C\/S deficiency)<\/li>\n<li>Purple toe syndrome (rare cholesterol embolisation)<\/li>\n<li>Hair loss<\/li>\n<li>Hepatotoxicitet (s\u00e4llsynt)<\/li>\n<li>INR instability &mdash; diet changes, acute illness, interacting drugs all destabilise<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kontraindikationer<\/h2>\n<ul>\n<li>Active bleeding<\/li>\n<li>Sv\u00e5r okontrollerad hypertoni<\/li>\n<li>Recent major surgery or trauma<\/li>\n<li>Active peptic ulcer<\/li>\n<li>Sv\u00e5r leversvikt<\/li>\n<li>Pregnancy &mdash; warfarin is teratogenic (first trimester) and causes fetal haemorrhage (third trimester); use LMWH<\/li>\n<li>Planned pregnancy (use LMWH)<\/li>\n<li>Inability to attend INR monitoring<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">L\u00e4kemedelsinteraktioner<\/h2>\n<ul>\n<li><strong>Many drugs alter INR &mdash; extensive interaction list.<\/strong> Notable: <strong>antibiotika<\/strong> (ciprofloxacin, metronidazole, trimethoprim-sulfamethoxazole, erythromycin, clarithromycin raise INR; rifampicin lowers it), <strong>amiodarone<\/strong> (roughly doubles INR), <strong>fluconazole, miconazole<\/strong> (raise INR substantially), <strong>phenytoin, carbamazepine, rifampicin<\/strong> (lower INR).<\/li>\n<li><strong>Dietary vitamin K<\/strong> &mdash; large changes in vitamin K intake (leafy greens) destabilise INR. Keep intake consistent rather than avoiding vitamin K entirely.<\/li>\n<li><strong>Alkohol<\/strong> &mdash; acute heavy intake raises INR; chronic heavy intake can lower it. Moderate, consistent intake is OK.<\/li>\n<li><strong>NSAIDs, SSRIs, antiplatelets<\/strong> &mdash; additive bleeding without INR change.<\/li>\n<li><strong>Warfarin sensitivity is genotype-dependent<\/strong> &mdash; CYP2C9 and VKORC1 variants affect required dose 2-3 fold.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">F\u00f6rvaring<\/h2>\n<p>Store Waf-5 below 25&deg;C. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">Vanliga fr\u00e5gor<\/h2>\n<h3 class=\"wp-block-heading\">Do I need blood tests on Waf-5?<\/h3>\n<p>Yes &mdash; INR monitoring is essential (every 3-4 days initially, stabilising to every 1-4 weeks). This is warfarin&rsquo;s main practical burden.<\/p>\n<h3 class=\"wp-block-heading\">What should I do if I cut myself while on Waf-5?<\/h3>\n<p>Applicera fast direkt tryck i 15-20 minuter utan att kontrollera. De flesta mindre sk\u00e4rs\u00e5r slutar bl\u00f6da normalt; bl\u00f6dning som forts\u00e4tter &gt;20 minuter eller genomtr\u00e4nger flera f\u00f6rband kr\u00e4ver akut medicinsk utv\u00e4rdering. Rapportera alla svarta eller blodiga avf\u00f6ringar, ljust r\u00f6tt rektalbl\u00f6dning, hematuri, of\u00f6rklarliga bl\u00e5m\u00e4rken, n\u00e4sbl\u00f6dning &gt;15 minuter eller mensbl\u00f6dning som \u00e4r mycket kraftigare \u00e4n vanligt.<\/p>\n<h3 class=\"wp-block-heading\">Can I take Waf-5 in pregnancy?<\/h3>\n<p>No &mdash; warfarin is teratogenic in first trimester and causes fetal haemorrhage in third. Switch to LMWH before conception.<\/p>\n<h3 class=\"wp-block-heading\">Vad h\u00e4nder om jag beh\u00f6ver opereras?<\/h3>\n<p>Inform the surgical team well in advance. Warfarin is typically stopped 5 days before major surgery; may require bridging with LMWH in high thrombosis risk.<\/p>\n<h3 class=\"wp-block-heading\">Where can I buy Waf-5 online?<\/h3>\n<p>You can buy Waf-5 (warfarin 5 mg, 30-180 tablets) from MedsBase with discreet packaging and worldwide shipping.<\/p>\n<h2 class=\"wp-block-heading\">Relaterade kardiovaskul\u00e4ra l\u00e4kemedel<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/sv\/aldactone\/\">Aldactone \u2014 Spironolakton<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/cordarone\/\">Cordarone \u2014 Amiodarone 100\/200 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/ecopril\/\">Ecopril \u2014 Clopidogrel 75 mg (trombocythemmare)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/lonitab\/\">Lonitab \u2014 Minoxidil 5 mg (oralt vaskul\u00e4rt dilaterande medel)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/rioci-1\/\">Rioci 1 \u2014 Riociguat 1 mg (sGC-stimulator f\u00f6r PAH)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/vymada\/\">Vymada \u2014 Sacubitril\/Valsartan ARNI<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/high-blood-pressure-medication\/\"><strong>Bl\u00e4ddra bland alla blodtryckss\u00e4nkande l\u00e4kemedel<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Medicinsk ansvarsfriskrivning.<\/strong> Denna sida \u00e4r endast avsedd f\u00f6r informations\u00e4ndam\u00e5l och ers\u00e4tter inte medicinsk r\u00e5dgivning fr\u00e5n en kvalificerad v\u00e5rdgivare. Hypertoni, hj\u00e4rtsvikt och arytmier kr\u00e4ver diagnos, uppf\u00f6ljning och dosindividualisering av en l\u00e4kare \u2014 anv\u00e4nd alltid betablockerare under medicinsk \u00f6vervakning.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Relaterade alternativ<\/h3>\n<p>Andra produkter inom <strong>Kroniska tillst\u00e5nd<\/strong> som kunder \u00e4ven tittar p\u00e5:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/sv\/p-nolol-sr\/\">P-Nolol SR<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/choltran-sachet\/\">Choltran Sachet<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/admenta\/\">Admenta<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/omnacortil\/\">Omnacortil<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/veenat\/\">Veenat<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Waf-5 is warfarin 5 mg tablets \u2014 the reference vitamin K antagonist. Introduced 1954; still essential for mechanical heart valves, moderate-severe mitral stenosis, and antiphospholipid syndrome where DOACs are contraindicated. Dose individualised to INR (2.0-3.0 most indications, 2.5-3.5 mechanical valves). Extensive drug and dietary interactions; CYP2C9\/VKORC1 genotype-dependent sensitivity. Regular INR monitoring mandatory. Reversed by vitamin K or 4-factor PCC.<\/p>","protected":false},"featured_media":59772,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3635,3141,3223,3342,3260,3356],"product_tag":[4741,4742],"class_list":{"0":"post-59771","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-coagulants","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","9":"product_cat-general-health","10":"product_cat-heart-blood-pressure","11":"product_cat-high-blood-pressure-medication","12":"product_tag-waf-5","13":"product_tag-warfarin","15":"first","16":"instock","17":"shipping-taxable","18":"purchasable","19":"product-type-variable","20":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product\/59771","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/comments?post=59771"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/media\/59772"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/media?parent=59771"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_brand?post=59771"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_cat?post=59771"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_tag?post=59771"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}